Unfortunately it seems probable that Respiri will conduct another capital raise according to the quarterly report:
The main things I'm thinking about are:
1. At what price will Respiri conduct their private placement at? If it's at a notable discount then that will be concerning. 2. Will they be able to announce some of the insurer or ACO contracts, or at least multiple healthcare organisations contracts before the capital raise? That would hopefully buffer the share price and make the raise less dilutive and at less of a discount. 3. Will this placement be the final raise before Respiri is hopefully cashflow positive in H2 2024?
The June quarterly report stated they hoped to finalise the insurer contracts during the September quarter, so hopefully they are very close to being signed and announced.
RSH Price at posting:
3.2¢ Sentiment: Buy Disclosure: Held
